On September 18, 2026, UBS Group AG bought 9.14 million shares of ALI HEALTH (00241) on the SEHK open market at an average price of HKD 3.0327 per share, involving about HKD 27.73 million. This was an on-exchange active trade, i.e., a direct dealing in the secondary market.
Prior to the acquisition, UBS Group AG's long position in ALI HEALTH was 1.29 billion shares, representing 7.98%; following the acquisition, the holding changed to 1.30 billion shares, with the long position ratio rising to 8.04%.